Holen Sie sich die Stockscreener-App
5.04
2.33%
-0.12
Handel nachbörslich:
5.25
0.21
+4.17%
Schlusskurs vom Vortag:
$5.16
Offen:
$5.15
24-Stunden-Volumen:
784.49K
Relative Volume:
0.86
Marktkapitalisierung:
$367.36M
Einnahmen:
$73.48M
Nettoeinkommen (Verlust:
$-108.30M
KGV:
-2.24
EPS:
-2.25
Netto-Cashflow:
$-67.17M
1W Leistung:
+21.15%
1M Leistung:
+49.11%
6M Leistung:
+10.77%
1J Leistung:
+205.45%
1-Tages-Spanne:
$4.96
$5.31
1-Wochen-Bereich:
$3.98
$5.61
52-Wochen-Spanne:
$1.135
$7.20
Personalis Inc Stock (PSNL) Company Profile
Firmenname
Personalis Inc
Sektor
Branche
Telefon
650-752-1300
Adresse
6600 DUMBARTON CIRCLE, FREMONT, CA
Vergleichen Sie PSNL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
5.04 | 367.36M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
403.13 | 159.89B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.73 | 142.45B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
491.70 | 37.95B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
106.93 | 30.97B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
148.99 | 26.72B | 15.50B | 1.33B | 2.16B | 7.34 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-17 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-06 | Hochstufung | Needham | Hold → Buy |
| 2022-01-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-11-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Herabstufung | Needham | Buy → Hold |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-20 | Bestätigt | Needham | Buy |
| 2021-05-06 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-12 | Bestätigt | Needham | Buy |
| 2020-11-06 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Eingeleitet | Citigroup | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-08-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-18 | Eingeleitet | Needham | Buy |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-07-15 | Eingeleitet | Cowen | Outperform |
| 2019-07-15 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-07-15 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Personalis Inc Aktie (PSNL) Neueste Nachrichten
Personalis reiterates 2025 revenue guidance of $80M-$90M with focus on MRD testing growth - MSN
HC Wainwright Raises Personalis (NASDAQ:PSNL) Price Target to $9.00 - Defense World
Companies Like Personalis (NASDAQ:PSNL) Are In A Position To Invest In Growth - Yahoo Finance
Barclays PLC Acquires 43,900 Shares of Personalis, Inc. (NASDAQ:PSNL) - The AM Reporter
JPMorgan Chase & Co. Has $34,000 Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Barclays PLC Increases Stock Holdings in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Personalis stock price target raised to $9 at H.C. Wainwright - Investing.com Australia
Personalis Inc.: Strong Financial Performance and Promising Future Prospects Drive Buy Rating - TipRanks
Will Personalis' Testing Growth And MRD Strategy Pay Off In 2025? - Nasdaq
Analyst Expectations For Personalis's Future - Benzinga
Personalis stock price target raised to $9 at H.C. Wainwright By Investing.com - Investing.com India
Personalis, Inc. (NASDAQ:PSNL) Q1 2025 Earnings Call Transcript - Insider Monkey
Personalis (PSNL) Receives Price Target Boost from Analyst | PSNL Stock News - GuruFocus
H.C. Wainwright Increases Price Target for Personalis (PSNL) to $9 | PSNL Stock News - GuruFocus
Personalis Reports Strong Q1 Growth in Genomics - TipRanks
Personalis Inc (PSNL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
Earnings call transcript: Personalis beats Q1 2025 earnings, stock rises By Investing.com - Investing.com South Africa
Personalis Inc (PSNL) Q1 2025 Earnings Call Highlights: Strong R - GuruFocus
Personalis Reports First Quarter 2025 Financial Results - BioSpace
Personalis: Q1 Earnings Snapshot - CTPost
Personalis (PSNL) Q1 2025 Earnings Reflects Strong Growth in Molecular Tests - GuruFocus
Personalis (PSNL) Q1 2025 Earnings Reflects Strong Growth in Mol - GuruFocus
Earnings call transcript: Personalis beats Q1 2025 earnings, stock rises - Investing.com
Personalis Inc (PSNL) Q1 2025 Earnings: EPS of -$0.24 Beats Esti - GuruFocus
Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Personalis Inc (PSNL) Q1 2025 Earnings: EPS of -$0.24 Beats Estimate, Revenue at $13.6M Misses Estimate - GuruFocus
PSNL Projects Diverse Revenue Streams Across Multiple Segments | PSNL Stock News - GuruFocus
Personalis (PSNL) Reports Strong Q1 Revenue and Testing Growth | PSNL Stock News - GuruFocus
Personalis, Inc. (NASDAQ:PSNL) Stocks Shoot Up 37% But Its P/S Still Looks Reasonable - simplywall.st
Invesco Ltd. Invests $82,000 in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Personalis Inc (PSNL) Q1 2025 Earnings Report Preview: What To E - GuruFocus
Personalis Inc (PSNL) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Personalis Inc (PSNL) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Market Momentum Report: Personalis Inc (PSNL)’s Negative Close at 3.78 - DWinneX
Results from Personalis Inc (PSNL) show potential - uspostnews.com
Examining the Potential Price Growth of Personalis Inc (PSNL) - knoxdaily.com
Personalis (PSNL) Reveals Promising Interim Results in Colorecta - GuruFocus
Personalis’ NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study - BioSpace
Personalis' NeXT Personal® Detects 100% of Colorectal Cancer Rel - GuruFocus
Investor’s Delight: Personalis Inc (PSNL) Closes Weak at 4.14, Down -1.90 - DWinneX
Gaining Ground: Personalis Inc (PSNL) Closes Lower at 3.51, Down -3.04 - DWinneX
PSNL Stock Sees Surge of Approximately 12.88% in Last Five Days - knoxdaily.com
Several Personalis Insiders Sell Shares Sending Potential Negative Signal - simplywall.st
Personalis and Academic Partners to Present Latest Data on UltraNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Personalis Inc (PSNL) produces promising results - uspostnews.com
Personalis to Announce First Quarter 2025 Financial Results - BioSpace
Is Personalis, Inc. (PSNL) the Best Multibagger Penny Stock to Buy According to Billionaires? - Insider Monkey
10 Best Multibagger Penny Stocks to Buy According to Billionaires - Insider Monkey
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection | PSNL Stock News - GuruFocus
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection - Business Wire
LPL Financial LLC Sells 6,773 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World
Finanzdaten der Personalis Inc-Aktie (PSNL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):